- Home
- KTCC vs ATRA Comparison
KTCC vs ATRA Comparison
Compare KTCC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- ATRA
- Stock Information
- Founded
- KTCC 1969
- ATRA 2012
- Country
- KTCC United States
- ATRA United States
- Employees
- KTCC N/A
- ATRA N/A
- Industry
- KTCC Electrical Products
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KTCC Technology
- ATRA Health Care
- Exchange
- KTCC Nasdaq
- ATRA Nasdaq
- Market Cap
- KTCC 41.4M
- ATRA 48.5M
- IPO Year
- KTCC N/A
- ATRA 2014
- Fundamental
- Price
- KTCC $3.16
- ATRA $7.11
- Analyst Decision
- KTCC
- ATRA Buy
- Analyst Count
- KTCC 0
- ATRA 6
- Target Price
- KTCC N/A
- ATRA $25.70
- AVG Volume (30 Days)
- KTCC 41.6K
- ATRA 178.5K
- Earning Date
- KTCC 02-04-2025
- ATRA 03-27-2025
- Dividend Yield
- KTCC N/A
- ATRA N/A
- EPS Growth
- KTCC N/A
- ATRA N/A
- EPS
- KTCC N/A
- ATRA N/A
- Revenue
- KTCC $514,394,000.00
- ATRA $100,439,000.00
- Revenue This Year
- KTCC N/A
- ATRA $1,281.31
- Revenue Next Year
- KTCC N/A
- ATRA N/A
- P/E Ratio
- KTCC N/A
- ATRA N/A
- Revenue Growth
- KTCC N/A
- ATRA 2111.34
- 52 Week Low
- KTCC $3.03
- ATRA $5.40
- 52 Week High
- KTCC $6.14
- ATRA $23.45
- Technical
- Relative Strength Index (RSI)
- KTCC 33.87
- ATRA 37.35
- Support Level
- KTCC $3.03
- ATRA $8.05
- Resistance Level
- KTCC $3.30
- ATRA $9.05
- Average True Range (ATR)
- KTCC 0.20
- ATRA 0.85
- MACD
- KTCC -0.01
- ATRA -0.06
- Stochastic Oscillator
- KTCC 13.83
- ATRA 2.23
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).